Paul Klecha, Partner

Houston, TX

O: (713) 623-4844 D: (713) 576-5044

A strategic patent practice centered on medical technologies

Paul Klecha is a partner in Patterson + Sheridan’s Houston office who helps clients of all sizes build, manage and monetize sophisticated IP portfolios in the United States and internationally. His practice is centered on medical devices and health technologies, where he represents innovators ranging from early-stage startups to multinational manufacturers.

Paul prepares and prosecutes patent applications across a broad range of medical device technologies, including surgical systems and instruments, implants, drug delivery platforms, wearable health devices, diagnostics, organ transplant systems and other integrated medical technologies. He works closely with engineering and executive teams to develop IP strategies aligned with business objectives.

In addition to medical devices, Paul advises clients on a range of life sciences technologies, including bioreactors, grafting methods, nutraceuticals, vaccines, sequencing technologies and CRISPR-based genome-editing systems. He has also represented multinational energy companies and global technology companies.

Beyond patent preparation and prosecution, Paul provides IP due diligence support for commercial product development, including sustainability analyses, IP risk assessments, freedom-to-operate analyses, and non-infringement and invalidity analyses.

An established technical foundation

Paul’s technical background enables him to quickly understand complex technologies and navigate evolving regulatory frameworks. Prior to practicing law, he worked in the R&D laboratory of a global biopharmaceutical company, where he conducted research supporting lead candidate selection and optimization. This hands-on experience provides practical insight into early-stage product development and informs his approach to protecting innovation through strategic IP planning.

Paul earned his J.D. from the University of Notre Dame Law School and his Master of Business and Science and Bachelor of Science in biotechnology from Rutgers University. While in law school, he was active in the Intellectual Property Law Society, the Student Bar Association and served as an editor for the Notre Dame Journal of Law, Ethics & Public Policy.

When he’s not in the office, Paul enjoys spending time with his wife and twin boys. He is an avid soccer fan and can occasionally be found playing in pick-up games around Houston.

Education

  • J.D., University of Notre Dame Law School, 2018
  • M.B.S., Biotechnology, Rutgers University, 2013
  • B.S., Biotechnology, Rutgers University, 2012

Bar Admissions

  • State Bar of Texas
  • United States Patent and Trademark Office

Special Honors

  • “Ones to Watch” in Patent Litigation and Patent Law, Best Lawyers in America®, 2024
  • School of Environmental and Biological Sciences General Honors

A strategic patent practice centered on medical technologies

Paul Klecha is a partner in Patterson + Sheridan’s Houston office who helps clients of all sizes build, manage and monetize sophisticated IP portfolios in the United States and internationally. His practice is centered on medical devices and health technologies, where he represents innovators ranging from early-stage startups to multinational manufacturers.

Paul prepares and prosecutes patent applications across a broad range of medical device technologies, including surgical systems and instruments, implants, drug delivery platforms, wearable health devices, diagnostics, organ transplant systems and other integrated medical technologies. He works closely with engineering and executive teams to develop IP strategies aligned with business objectives.

In addition to medical devices, Paul advises clients on a range of life sciences technologies, including bioreactors, grafting methods, nutraceuticals, vaccines, sequencing technologies and CRISPR-based genome-editing systems. He has also represented multinational energy companies and global technology companies.

Beyond patent preparation and prosecution, Paul provides IP due diligence support for commercial product development, including sustainability analyses, IP risk assessments, freedom-to-operate analyses, and non-infringement and invalidity analyses.

An established technical foundation

Paul’s technical background enables him to quickly understand complex technologies and navigate evolving regulatory frameworks. Prior to practicing law, he worked in the R&D laboratory of a global biopharmaceutical company, where he conducted research supporting lead candidate selection and optimization. This hands-on experience provides practical insight into early-stage product development and informs his approach to protecting innovation through strategic IP planning.

Paul earned his J.D. from the University of Notre Dame Law School and his Master of Business and Science and Bachelor of Science in biotechnology from Rutgers University. While in law school, he was active in the Intellectual Property Law Society, the Student Bar Association and served as an editor for the Notre Dame Journal of Law, Ethics & Public Policy.

When he’s not in the office, Paul enjoys spending time with his wife and twin boys. He is an avid soccer fan and can occasionally be found playing in pick-up games around Houston.



Back to Full List